Results

Total Results: 1,166 records

Showing results for "loss".

261. Topic 0494 Tacrolimus Monitoring and Treatment Renal Transplantation NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0583-131115.pdf
     March 13, 2013 - Cyclosporine), are nephrotoxic and therefore also the same agents responsible for long-term kidney graft loss

262. Topic 0613 Tympanostomy Tubes NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
     November 03, 2014 - when it persists beyond three months.1 At any given time, 5% of children aged 2-4 years have hearing loss

263. Enzyme Replacement Therapy for Lysosomal Storage Disorders | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol
     October 05, 2011 - Symptoms may include respiratory insufficiency, hearing loss, joint movement restriction, enlargement … Symptoms may include short stature, organomegaly, joint stiffness, hearing loss, progressive cognitive … central and peripheral nervous system involvement in this form of the disease, but there is no neuronal loss

264. Transparency of Reporting Requirements: Management of Infertility (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
     September 02, 2016 - Ovary Syndrome/therapy"[Mesh] OR "Endometriosis/therapy"[Mesh] OR "Nutrition Therapy"[Mesh] OR "Weight Loss … Firmagon”[tiab] OR “ganirelix”[tiab] OR “antagon”[tiab] OR exercise[tiab] OR diet[tiab] OR “weight loss … • Interventions: o Clomiphene citrate, letrozole, diet/exercise/other weight loss strategies, timed

265. Antiplatelet-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
     September 01, 2013 - alleles than those with no loss-of-function alleles. … alleles than those with no loss-of-function alleles. … design (not case control, in keeping with our inclusion criteria), and no studies had substantial loss … (All analyses assumed a dominant model for loss-of-function alleles; analyses under an alternative … We found some evidence supporting a significant association between loss-of-function CYP2C19 variants

266. Technical Brief: Whole Body Vibration Therapy for Osteoporosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoporosis-vibration-therapy/research-protocol
     December 09, 2010 - been shown to be associated with an increased risk of death. 1 Fractures can also cause pain, height loss … Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical … Subtle shake-up in bone-loss research. Aerospace America 2002;40:16-8. Rittweger J.

267. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - , loss of water content, loss of shock-absorbing capacity, and bone spur formation. … Symptoms can include numbness, pain, or loss of function (e.g., gait issues, grip weakness, bowel and … OA is a chronic condition characterized by the progressive loss of cartilage in one or more joints. … Physicians can recommend exercise, physical and/or occupational therapy, and weight loss. … Physicians can recommend exercise, physical and/or occupational therapy, and weight loss.

268. Osteoporosis-Vibration-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
     January 01, 2020 - been shown to be associated with an increased risk of death.1 Fractures can also cause pain, height loss … Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical … Subtle shake-up in bone-loss research. Aerospace America 2002;40:16- 8. 32. Rittweger J.

269. Suppl-2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - healthy-worker bias, volunteer bias, selection of controls into case-control studies, differential loss-to-followup … section, we provide an example of how conditioning on a common effect can result from differential loss … Some forms of selection bias, such as differential loss to followup, can be corrected by statistical

270. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - advocated for management of chronic gout include a combination of lifestyle changes, including weight loss … and cherries) compared with nonspecific dietary advice (counseling about the importance of weight loss … in gout patients without additional data (e.g., it is always indicated to recommend dietary weight loss … and even restriction of high purine foods) compared with standard healthy diet advice and weight loss … The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the

271. Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
     November 01, 2013 - Key points for communication strategies are as follows: • Framing (gain/loss) versus narratives (yes … /no)—Loss- framed messages used in conjunction with narratives were more persuasive than (1) loss-framed … • Framing (gain/loss) versus targeting (yes/no)—The loss- framed message used in combination with

272. Tonsillectomy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
     February 10, 2016 -  of  these  sleep-­related  disorders  include  an  attributable  average  intelligence   quotient  loss … CPAP  is  variable.14-18  Other  approaches  advocated  in  certain  circumstances   include  weight  loss … Some  comments  also  discussed  intermediate  outcomes  such  as  intraoperative  blood  loss.   … of  age)   with  OSDB   who  are   overweight  or   obese     Tonsillectomy     -­CPAP   -­Weight  loss …  (see  Table  2   for  full  details)    (KQ  1d)     • Tonsillectomy†     • CPAP     • Weight  loss

273. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - surgical chronic kidney disease (defined as chronic kidney disease as a result of surgical nephron loss … Source: www.effectivehealthcare.ahrq.gov Published online: April 20, 2015 7 o Hematuria o Loss … o Peri-operative outcomes o Blood loss (cc or mL) o Blood transfusion (yes or no) o Length of stay … : • Urologic complications: • Acute kidney Injury • Hemorrhage • Urine leak • Hematuria • Loss … Source: www.effectivehealthcare.ahrq.gov Published online: April 20, 2015 12 o Blood loss (cc or

274. Assessing the Quality of Individual Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
     January 01, 2010 - (II) Apply one of several available tools that consider Intention-to-treat analysis Differential loss … to followup between the compared groups or overall high loss to followup Conflict of interest Apply

275. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-effectiveness-of-interventions-designed-to-support-children-in-transition-from-pediatric-care-to-adult-care-with-special-health-care-needs-ineffective-transition-planning-can-have-significant-negative-consequences
     January 07, 2013 - Successful transition planning to adult care without loss or discontinuity of services, satisfaction

276. Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
     November 01, 2016 - issues related to living with diabetes; b) a structured dietary intervention (related to weight loss

277. Using Deliberative Methods to Engage the Public: Facilitating a Deliberative Session (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
     January 11, 2017 - • What researchers will learn: o Concerns about loss of patient/doctor authority o How people

278. Er r or Rate Reduction Regarding Lower Limb Prosthesis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
     March 16, 2017 - Objectives for the Systematic Review An estimated 1.9 million people in the U.S. are living with limb loss … LLP candidates are a heterogeneous group with distinct needs dependent upon age, etiology of limb loss … Specifically, patients who are in need of LLPs are heterogeneous in terms of etiology of limb loss, … “Estimating the Prevalence of Limb Loss in the United States: 2005 to 2050.”

279. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - characterized by a subjective decline in cognition and objective neurological testing threshold without a loss … cancer, cardiovascular disease, diabetes, delirium, thyroid disorders, chronic kidney disease, and loss … Studies with longer durations and followup may experience different rates of mortality and loss to followup … Long-term impact of behavioral weight loss intervention on cognitive function.

280. Who Uses Exenatide For Glucose Control in Diabetes Mellitus? A Retrospective Cohort Study of a New Therapy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-glucose-control/research
     August 04, 2010 - non-inferiority relative to insulin glargine 10 and insulin aspart. 11 These trials also demonstrated weight loss … individuals with obesity was highest in the group prescribed exenatide, an anticipated finding as weight loss … The known side-effect of weight loss could have motivated use of this medication, although we cannot